Protocol of randomized controlled trial of potentized estrogen in homeopathic treatment of chronic pelvic pain associated with endometriosis

 

 Buy Article Permissions and Reprints

Background: Endometriosis is a chronic inflammatory disease that causes difficult-to-treat pelvic pain. Thus being, many patients seek help in complementary and alternative medicine, including homeopathy. The effectiveness of homeopathic treatment for endometriosis is controversial due to the lack of evidences in the literature. The aim of the present randomized controlled trial is to assess the efficacy of potentized estrogen compared to placebo in the treatment of chronic pelvic pain associated with endometriosis.

Methods/design: The present is a randomized, double-blind, placebo-controlled trial of a homeopathic medicine individualized according to program ‘New Homeopathic Medicines: use of modern drugs according to the principle of similitude’ (http://newhomeopathicmedicines.com). Women with endometriosis, chronic pelvic pain and a set of signs and symptoms similar to the adverse events caused by estrogen were recruited at the Endometriosis Unit of Division of Clinical Gynecology, Clinical Hospital, School of Medicine, University of São Paulo (Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo – HCFMUSP). The participants were selected based on the analysis of their medical records and the application of self-report structured questionnaires. A total of 50 women meeting the eligibility criteria will be randomly allocated to receive potentized estrogen or placebo. The primary clinical outcome measure will be severity of chronic pelvic pain. Statistical analysis will be performed on the intention-to-treat and per-protocol approaches comparing the effect of the homeopathic medicine versus placebo after 24 weeks of intervention.

Discussion: The present study was approved by the research ethics committee of HCFMUSP and the results are expected in 2016.

Trial registration: ClinicalTrials.gov Identifier: https://clinicaltrials.gov/ct2/show/NCT02427386.

• References

• 1 Bellelis P., Podgaec S., Dias Jr. J.A., Gonzalez M., Baracat E.C., Abrão M.S. Epidemiological and clinical aspects of pelvic endometriosis – a case series. Rev Assoc Med Bras 56 (04) 2010; 467-471.
  CrossrefPubMedGoogle Scholar
• 2 Podgaec S. Coleção Febrasgo: Endometriose. 2014. Elsevier; Rio de Janeiro.:
  Google Scholar
• 3 Abrao M.S., Gonçalves M.O., Dias Jr. J.A., Podgaec S., Chamie L.P., Blasbalg R. Comparison between clinical examination, transvaginal sonography and magnetic resonance imaging for the diagnosis of deep endometriosis. Hum Reprod 22 (12) 2007; 3092-3097.
  CrossrefPubMedGoogle Scholar
• 4 Goncalves M.O., Dias Jr. J.A., Podgaec S., Averbach M., Abrão M.S. Transvaginal ultrasound for diagnosis of deeply infiltrating endometriosis. Int J Gynaecol Obstet 104 (02) 2009; 156-160.
  CrossrefPubMedGoogle Scholar
• 5 Goncalves M.O., Podgaec S., Dias Jr. J.A., Gonzalez M., Abrao M.S. Transvaginal ultrasonography with bowel preparation is able to predict the number of lesions and rectosigmoid layers affected in cases of deep endometriosis, defining surgical strategy. Hum Reprod 25 (03) 2010; 665-671.
  CrossrefPubMedGoogle Scholar
• 6 Vimercati A., Achilarre M.T., Scardapane A. et al. Accuracy of transvaginal sonography and contrast-enhanced magnetic resonance-colonography for the presurgical staging of deep infiltrating endometriosis. Ultrasound Obstet Gynecol 40 (05) 2012; 592-603.
  CrossrefPubMedGoogle Scholar
• 7 Exacoustos C., Manganaro L., Zupi E. Imaging for the evaluation of endometriosis and adenomyosis. Best Pract Res Clin Obstet Gynaecol 28 (05) 2014; 655-681.
  CrossrefPubMedGoogle Scholar
• 8 Dmowski W.P., Lesniewicz R., Rana N., Pepping P., Nowisalehi M. Changing trends in the diagnosis of endometriosis: a comparative study of women with pelvic endometriosis presenting with chronic pelvic pain or infertility. Fertil Steril 67 (02) 1997; 238-243.
  CrossrefPubMedGoogle Scholar
• 9 Luisi S., Lazzeri L., Ciani V., Petraglia F. Endometriosis in Italy: from cost estimates to new medical treatment. Gynecol Endocrinol 25 (11) 2009; 734-740.
  CrossrefPubMedGoogle Scholar
• 10 Giudice L.C., Kao L.C. Endometriosis. Lancet 364 2004; 1789-1799.
  CrossrefPubMedGoogle Scholar
• 11 Harris H.R., Costenbader K.H., Mu F. et al. Endometriosis and the risks of systemic lupus erythematosus and rheumatoid arthritis in the Nurses’ Health Study II. Ann Rheum Dis 0 2015; 1-6.
  PubMedGoogle Scholar
• 12 Kvaskoff M., Mu F., Terry K.L. et al. Endometriosis: a high-risk population for major chronic diseases. Hum Reprod Update 21 (04) 2015; 500-516.
  CrossrefPubMedGoogle Scholar
• 13 Guo S.W. Endometriosis and ovarian cancer: potential benefits and harms of screening and risk-reducing surgery. Fertil Steril 2015. pii: S0015-0282(15) 01760-4.
  Google Scholar
• 14 Lu Y., Cuellar-Partida G., Painter J.N. et al. Australian Ovarian Cancer Study; International Endogene Consortium (IEC). Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Hum Mol Genet 24 (20) 2015; 5955-5964.
  CrossrefPubMedGoogle Scholar
• 15 Cavaggioni G., Lia C., Resta S. et al. Are mood and anxiety disorders and alexithymia associated with endometriosis? A preliminary study. Biomed Res Int 2014 2014; 786830.
  PubMedGoogle Scholar
• 16 Laganà A.S., Condemi I., Retto G. et al. Analysis of psychopathological comorbidity behind the common symptoms and signs of endometriosis. Eur J Obstet Gynecol Reprod Biol 194 2015; 30-33.
  CrossrefPubMedGoogle Scholar
• 17 Friedl F., Riedl D., Fessler S. et al. Impact of endometriosis on quality of life, anxiety, and depression: an Austrian perspective. Arch Gynecol Obstet 292 (06) 2015; Jun 26 1393-1399.
  CrossrefPubMedGoogle Scholar
• 18 Matalliotakis I., Cakmak H., Matalliotakis M., Kappou D., Arici A. High rate of allergies among women with endometriosis. J Obstet Gynaecol 32 (03) 2012; 291-293.
  CrossrefPubMedGoogle Scholar
• 19 Bungum H.F., Vestergaard C., Knudsen U.B. Endometriosis and type 1 allergies/immediate type hypersensitivity: a systematic review. Eur J Obstet Gynecol Reprod Biol 179 2014; 209-215.
  CrossrefPubMedGoogle Scholar
• 20 Ferrero S., Pretta S., Bertoldi S. et al. Increased frequency of migraine among women with endometriosis. Hum Reprod 19 (12) 2004; 2927-2932.
  CrossrefPubMedGoogle Scholar
• 21 Tietjen G.E., Bushnell C.D., Herial N.A., Utley C., White L., Hafeez F. Endometriosis is associated with prevalence of comorbid conditions in migraine. Headache 47 (07) 2007; 1069-1078.
  CrossrefPubMedGoogle Scholar
• 22 Nyholt D.R., Gillespie N.G., Merikangas K.R., Treloar S.A., Martin N.G., Montgomery G.W. Common genetic influences underlie comorbidity of migraine and endometriosis. Genet Epidemiol 33 (02) 2009; 105-113.
  CrossrefPubMedGoogle Scholar
• 23 Yang M.H., Wang P.H., Wang S.J., Sun W.Z., Oyang Y.J., Fuh J.L. Women with endometriosis are more likely to suffer from migraines: a population-based study. PLoS One 7 (03) 2012; e33941.
  CrossrefPubMedGoogle Scholar
• 24 Nunes F.R., Ferreira J.M., Bahamondes L. Pain threshold and sleep quality in women with endometriosis. Eur J Pain 19 (01) 2015; 15-20.
  CrossrefPubMedGoogle Scholar
• 25 Campin L., Borghese B., Marcellin L., Santulli P., Bourret A., Chapron C. Urinary functional disorders bound to deep endometriosis and to its treatment: review of the literature. J Gynecol Obstet Biol Reprod (Paris) 43 (06) 2014; 431-442.
  CrossrefPubMedGoogle Scholar
• 26 Hansen K.E., Kesmodel U.S., Baldursson E.B., Kold M., Forman A. Visceral syndrome in endometriosis patients. Eur J Obstet Gynecol Reprod Biol 179 2014; 198-203.
  CrossrefPubMedGoogle Scholar
• 27 Rodgers A.K., Falcone T. Treatment strategies for endometriosis. Expert Opin Pharmacother 9 2008; 243-255.
  CrossrefPubMedGoogle Scholar
• 28 Vercellini P., Crosignani P.G., Somigliana E., Berlanda N., Barbara G., Fedele L. Medical treatment for rectovaginal endometriosis: what is the evidence?. Hum Reprod 24 (10) 2009; 2504-2514.
  CrossrefPubMedGoogle Scholar
• 29 Febrasgo. Endometriose em mulheres com dor pélvica crônica: tratamento clínico [Endometriosis in women with chronic pelvic pain: clinical treatment]. Associação Médica Brasileira e Conselho Federal de Medicina: Projeto Diretrizes 2011 Available at: http://www.projetodiretrizes.org.br/diretrizes10/endometriose_em_mulheres_dor_pelvica_cronica.pdf.
  PubMed
• 30 Teixeira M.Z., Guedes C.H., Barreto P.V., Martins M.A. The placebo effect and homeopathy. Homeopathy 99 (02) 2010; 119-129.
  Article in Thieme ConnectPubMedGoogle Scholar
• 31 Nuhn T., Lüdtke R., Geraedts M. Placebo effect sizes in homeopathic compared to conventional drugs – a systematic review of randomised controlled trials. Homeopathy 99 (01) 2010; 76-82.
  Article in Thieme ConnectPubMedGoogle Scholar
• 32 Shang A., Huwiler-Müntener K., Nartey L. et al. Are the clinical effects of homoeopathy placebo effects? Comparative study of placebo-controlled trials of homoeopathy and allopathy. Lancet 366 9487 2005; 726-732.
  CrossrefPubMedGoogle Scholar
• 33 Shaw D.M. Homeopathy is where the harm is: five unethical effects of funding unscientific ‘remedies’. J Med Ethics 36 (03) 2010; 130-131.
  CrossrefPubMedGoogle Scholar
• 34 Brien S., Lachance L., Prescott P., McDermott C., Lewith G. Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial. Rheumatology 50 (06) 2011; 1070-1082.
  CrossrefPubMedGoogle Scholar
• 35 Linde K., Clausius N., Ramirez G. et al. Are the clinical effects of homeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 350 9081 1997; 834-843.
  CrossrefPubMedGoogle Scholar
• 36 Taylor M.A., Reilly D., Llewellyn-Jones R.H., McSharry C., Aitchison T.C. Randomised controlled trials of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. BMJ 321 7259 2000; 471-476.
  CrossrefPubMedGoogle Scholar
• 37 Jonas W.B., Anderson R.L., Crawford C.C., Lyons J.S. A systematic review of the quality of homeopathic clinical trials. BMC Complement Altern Med 1 (01) 2001; 12.
  CrossrefPubMedGoogle Scholar
• 38 Jacobs J., Jonas W.B., Jiménez-Pérez M., Crothers D. Homeopathy for childhood diarrhea: combined results and metaanalysis from three randomized, controlled clinical trials. Pediatr Infect Dis J 22 (03) 2003; 229-234.
  PubMedGoogle Scholar
• 39 McCarney R.W., Linde K., Lasserson T.J. Homeopathy for chronic asthma. Cochrane Database Syst Rev 1 2004; CD000353.
  CrossrefPubMedGoogle Scholar
• 40 Mathie R.T., Lloyd S.M., Legg L.A. et al. Randomised placebo-controlled trials of individualised homeopathic treatment: systematic review and meta-analysis. Syst Rev 3 2014; 142.
  CrossrefPubMedGoogle Scholar
• 41 Webster’s new world medical dictionary. 3a edn. New Jersey:Wiley Publishing, 2008.
  PubMed
• 42 Teixeira M.Z. Semelhante cura semelhante: o princípio de cura homeopático fundamentado pela racionalidade médica e científica [Like cures like: the homeopathic cure principle based on medical and scientific reason]. 1998. Editorial Petrus; São Paulo.:
  Google Scholar
• 43 Teixeira M.Z. Similitude in modern pharmacology. Br Homeopath J 88 1999; 112-120.
  Article in Thieme ConnectPubMedGoogle Scholar
• 44 Teixeira M.Z. Evidence of the principle of similitude in modern fatal iatrogenic events. Homeopathy 95 2006; 229-236.
  Article in Thieme ConnectPubMedGoogle Scholar
• 45 Teixeira M.Z. NSAIDs, myocardial infarction, rebound effect and similitude. Homeopathy 96 2007; 67-68.
  Article in Thieme ConnectPubMedGoogle Scholar
• 46 Teixeira M.Z. Bronchodilators, fatal asthma, rebound effect and similitude. Homeopathy 96 2007; 135-137.
  Article in Thieme ConnectPubMedGoogle Scholar
• 47 Teixeira M.Z. Antidepressants, suicidality and rebound effect: evidence of similitude?. Homeopathy 98 2009; 114-121.
  Article in Thieme ConnectPubMedGoogle Scholar
• 48 Teixeira M.Z. Statins withdrawal, vascular complications, rebound effect and similitude. Homeopathy 99 2010; 255-262.
  Article in Thieme ConnectPubMedGoogle Scholar
• 49 Teixeira M.Z. Rebound acid hypersecretion after withdrawal of gastric acid suppressing drugs: new evidence of similitude. Homeopathy 100 2011; 148-156.
  Article in Thieme ConnectPubMedGoogle Scholar
• 50 Teixeira M.Z. Antiresorptive drugs (bisphosphonates), atypical fractures and rebound effect: new evidence of similitude. Homeopathy 101 2012; 231-242.
  Article in Thieme ConnectPubMedGoogle Scholar
• 51 Teixeira M.Z. Rebound effect of drugs: fatal risk of conventional treatment and pharmacological basis of homeopathic treatment. Int J High Dilution Res 11 (39) 2012; 69-106.
  PubMedGoogle Scholar
• 52 Teixeira M.Z. Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude. Homeopathy 102 2013; 215-224.
  Article in Thieme ConnectPubMedGoogle Scholar
• 53 Teixeira M.Z. Rebound effect of modern drugs: serious adverse event unknown by health professionals. Rev Assoc Med Bras 59 2013; 629-638.
  CrossrefPubMedGoogle Scholar
• 54 Teixeira M.Z. ‘Paradoxical strategy for treating chronic diseases’: a therapeutic model used in homeopathy for more than two centuries. Homeopathy 94 2005; 265-266.
  Article in Thieme ConnectPubMedGoogle Scholar
• 55 Teixeira M.Z. ‘Paradoxical pharmacology’: therapeutic strategy used by the ‘homeopathic pharmacology’ for more than two centuries. Int J High Dilution Res 13 (48) 2014; 207-226.
  PubMedGoogle Scholar
• 56 Bond R.A. Is paradoxical pharmacology a strategy worth pursuing?. Trends Pharmacol Sci 22 2001; 273-276.
  CrossrefPubMedGoogle Scholar
• 57 Yun A.J., Lee P.Y., Bazar K.A. Paradoxical strategy for treating chronic diseases where the therapeutic effect is derived from compensatory response rather than drug effect. Med Hypotheses 64 2005; 1050-1059.
  CrossrefPubMedGoogle Scholar
• 58 Page C. Paradoxical pharmacology: turning our pharmacological models upside down. Trends Pharmacol Sci 32 2011; 197-200.
  CrossrefPubMedGoogle Scholar
• 59 Davies C.J., Davies D.M. Paradoxical reactions to commonly used drugs. Adverse Drug React Bull 211 2011; 807-810.
  PubMedGoogle Scholar
• 60 Bond R.A., Giles H. For the love of paradox: from neurobiology to pharmacology. Behav Pharmacol 22 2011; 385-389.
  CrossrefPubMedGoogle Scholar
• 61 Smith S.W., Hauben M., Aronson J.K. Paradoxical and bidirectional drug effects. Drug Saf 35 2012; 173-189.
  PubMedGoogle Scholar
• 62 Bristow M.R. Beta-adrenergic receptor blockade in chronic heart failure. Circulation 101 2000; 558-569.
  CrossrefPubMedGoogle Scholar
• 63 Ho C.Y. Hypertrophic cardiomyopathy in 2012. Circulation 125 2012; 1432-1438.
  CrossrefPubMedGoogle Scholar
• 64 Dickey B.F., Walker J.K., Hanania N.A., Bond R.A. Beta-adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol 10 2010; 254-259.
  CrossrefPubMedGoogle Scholar
• 65 Cui X., Kobayashi Y., Akashi M., Okayasu R. Metabolism and the paradoxical effects of arsenic: carcinogenesis and anticancer. Curr Med Chem 15 2008; 2293-2304.
  CrossrefPubMedGoogle Scholar
• 66 Platanias L.C. Biological responses to arsenic compounds. J Biol Chem 284 2009; 18583-18587.
  CrossrefPubMedGoogle Scholar
• 67 Loffing J. Paradoxical antidiuretic effect of thiazides in diabetes insipidus: another piece in the puzzle. Am Soc Nephrol 15 2004; 2948-2950.
  CrossrefPubMedGoogle Scholar
• 68 Kovács I. Examination of the rebound effect of biphasic oral contraceptives. Ther Hung 38 1990; 110-113.
  PubMedGoogle Scholar
• 69 Adám J. How rapid is the return of fertility after the use of Tri-Regol oral contraceptive?. Ther Hung 40 (01) 1992; 16-19.
  PubMedGoogle Scholar
• 70 Seeman P., Madras B. Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis. Behav Brain Res 130 2002; 79-83.
  CrossrefPubMedGoogle Scholar
• 71 Engert V., Pruessner J.C. Dopaminergic and noradrenergic contributions to functionality in ADHD: the role of methylphenidate. Curr Neuropharmacol 6 (04) 2008; 322-328.
  CrossrefPubMedGoogle Scholar
• 72 Teixeira M.Z. Homeopathic use of modern medicines: utilisation of the curative rebound effect. Med Hypotheses 60 2003; 276-283.
  CrossrefPubMedGoogle Scholar
• 73 Teixeira M.Z. New homeopathic medicines: use of modern drugs according to the principle of similitude. Homeopathy 100 2011; 244-252.
  Article in Thieme ConnectPubMedGoogle Scholar
• 74 Teixeira M.Z. Homeopathic use of modern drugs: therapeutic application of the organism paradoxical reaction or rebound effect. Int J High Dilution Res 10 (37) 2011; 338-352.
  PubMedGoogle Scholar
• 75 Teixeira M.Z. ‘New Homeopathic Medicines’ database: a project to employ conventional drugs according to the homeopathic method of treatment. Eur J Integr Med 5 2013; 270-278.
  CrossrefPubMedGoogle Scholar
• 76 The United States Pharmacopeial Convention. The United States pharmacopeia dispensing information. 24th edn. Easton: Mack Printing Co, 2004.
  PubMed
• 77 Teixeira M.Z. New homeopathic medicines: use of modern drugs according to the principle of similitude. Vol 3 2010. Marcus Zulian Teixeira; São Paulo: Available at: http://www.newhomeopathicmedicines.com.
  Google Scholar
• 78 Teixeira M.Z. Estudo quali-quantitativo para avaliar a eficácia e a efetividade do tratamento homeopático individualizado na rinite alérgica perene [Quali-quantitative clinical trial to evaluate the efficacy and the effectiveness of individualized homeopathic treatment in perennial allergic rhinitis]. [thesis] 2009. Faculdade de Medicina, Universidade de São Paulo; São Paulo: Available at: http://www.teses.usp.br/teses/disponiveis/5/5159/tde-10062009-102220/en.php.
  Google Scholar
• 79 Teixeira M.Z. Effectiveness of individualized homeopathic treatment in perennial allergic rhinitis (PAR). Int J High Dilution Res 8 (28) 2009; 141-143.
  PubMedGoogle Scholar
• 80 Bignamini M., Bertoli A., Consolandi A. et al. A controlled double-blind clinical study of 15 CH barium carbonate vs. placebo in a group of hypertensive inmates of 2 homes for the aged. Clin Ter 122 (06) 1987; 429-436.
  PubMedGoogle Scholar
• 81 Frei H., Everts R., von Ammon K. et al. Randomised controlled trials of homeopathy in hyperactive children: treatment procedure leads to an unconventional study design. Experience with open-label homeopathic treatment preceding the Swiss ADHD placebo controlled, randomised, double-blind, cross-over trial. Homeopathy 96 2007; 35-41.
  Article in Thieme ConnectPubMedGoogle Scholar
• 82 Hill P.B., Hoare J., Lau-Gillard P., Rybnicek J., Mathie R.T. Pilot study of the effect of individualised homeopathy on the pruritus associated with atopic dermatitis in dogs. Vet Rec 164 (12) 2009; 364-370.
  CrossrefPubMedGoogle Scholar
• 83 Lorençatto C., Vieira M.J.N., Pinto C.L.B., Petta C.A. Avaliação da frequência de depressão em pacientes com endometriose e dor pélvica [Evaluation of the frequency of depression in patients with endometriosis and pelvic pain]. Rev Assoc Med Bras 48 (03) 2002; 217-221.
  CrossrefPubMedGoogle Scholar
• 84 Fernandez I., Reid C., Dziurawiec S. Living with endometriosis: the perspective of male partners. J Psychosom Res 61 (04) 2006; 433-438.
  CrossrefPubMedGoogle Scholar
• 85 Sepulcri R.P., Amaral V.F. Depressive symptoms, anxiety and quality of life in womem with pelvic endometriosis. Eur J Obstet Gynecol Reprod Biol 142 (01) 2009; 53-56.
  CrossrefPubMedGoogle Scholar
• 86 Thoth B. Stress, inflammation and endometriosis: are patients stuck between a rock and a hard place?. J Mol Med (Berl) 88 (03) 2010; 223-225.
  CrossrefPubMedGoogle Scholar
• 87 Beck A.T., Steer R.A. Beck anxiety inventory manual. 1993. Psychological Corporation (Harcourt Brace and Company); San Antonio.:
  Google Scholar
• 88 Beck A.T., Steer R.A., Brown G.K. Manual of beck depression inventory – II. 1996. Psychological Corporation (Harcourt Brace and Company); San Antonio.:
  Google Scholar
• 89 Farmacopéia Homeopática Brasileira [Brazilian homeopathic pharmacopoeia]. 3rd edn. Brasilia: Anvisa. Available at: http://www.anvisa.gov.br/hotsite/farmacopeiabrasileira/conteudo/3a_edicao.pdf 2011.
  PubMed
• 90 Ware J.E., Sherbourne C.D. The MOS 36-Item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care 30 1992; 473-483.
  CrossrefPubMedGoogle Scholar
• 91 Ciconelli R.M., Ferra M.B., Santos W., Meinão I., Quaresma M.R. Tradução para a língua portuguesa e validação do questionário genérico de avaliação de qualidade de vida SF-36 (Brasil SF-36) [Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure]. Rev Bras Reumatol 39 (03) 1999; 143-150.
  PubMedGoogle Scholar
• 92 Bayoglu Tekin Y., Dilbaz B., Altinbas S.K., Dilbaz S. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Fertil Steril 95 (02) 2011; 492-496.
  CrossrefPubMedGoogle Scholar
• 93 Kirwood B.R., Sterne J.A.C. Essential medical statistics. 2nd edn 2006. Blackwell Science; Massachusetts: pp 502.
  Google Scholar
• 94 Begg C., Cho M., Eastwood S. et al. Improving the quality of reporting of randomized controlled trials – The CONSORT statement. JAMA 276 (08) 1996; 637-639.
  CrossrefPubMedGoogle Scholar
• 95 Dean M.E., Coulter M.K., Fisher P., Jobst K.A., Walach H. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. Homeopathy 96 (01) 2007; 42-45.
  Article in Thieme ConnectPubMedGoogle Scholar